We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?
Review multidisciplinary care team approaches to managing cardio-renal-metabolic disease using emerging evidence and evolving treatment guidelines.
In this live webinar, a multidisciplinary faculty panel will review emerging evidence and evolving treatment guidelines related to cardio-renal-metabolic comorbidities (ie, type 2 diabetes, heart failure, chronic kidney disease, and management of post-MI) using clinical patience case vignettes.
1:30 – 1:35 PM
| Welcome and Introduction Melissa Magwire, RN |
1:35 – 1:45 PM
| Cardiologist Best Practices in the Management of Cardiometabolic Renal Outcomes Keith Miller, MD |
1:45 – 1:55 PM
| Nursing Best Practices in the Management of Cardiometabolic Renal Outcomes Melissa Magwire, RN |
1:55 – 2:05 PM | Pharmacy Best Practices in the Management of Cardiometabolic Renal Outcomes Matthew Bullington, PharmD
|
2:05 – 2:15 PM
| APP Best Practices in the Management of Cardiometabolic Renal Outcomes Dawn M. Denicola, NP
|
2:15 – 2:25 PM | Expert Panel Discussion – Pulling It All Together All Faculty
|
2:25 – 2:30 PM | Live Q&A All Faculty
|
In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.
Host:
Melissa Magwire, RN, MSN, CDE
Program Director, Cardiometabolic Center Alliance
Kansas City, MO
Melissa Magwire has reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months:
Consulting Fees: Amgen, Boehringer Ingelheim, Novo Nordisk
Faculty:
Matthew Bullington, PharmD
MHP Primary and Specialty Care
Shelbyville, IN
Matthew Bullington has reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months:
Ownership Interest: Lexicon Pharmaceuticals, Inc.
Dawn M. Denicola, FNP-C
Clinical Director, Heart Care Center
Heart Failure Coordinator
Our Lady of the Lake Regional Medical Center
Baton Rouge, LA
Dawn Denicola has reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months:
Has reported no relevant relationships
Keith Miller, MD
Cardiologist
Bryan Heart
Lincoln, NE
Dr. Miller has reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months:
Has reported no relevant relationships at this time
Reviewers/Content Planners/Authors:
After participating in this educational activity, participants should be better able to:
This activity is designed to meet the educational needs of cardiologists, nephrologists, and primary care physicians, as well as all other physicians, physician assistants, nurse practitioners, nurses, pharmacists, and other members of the interprofessional team who are involved in the management of patients with CVRM.
This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credit(s) for learning and change.
This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credit(s) for learning and change. In support of improving patient care, Global Learning Collaborative (GLC) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Global Learning Collaborative (GLC) designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Global Learning Collaborative (GLC) designates this activity for 1 nursing contact hour. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Global Learning Collaborative (GLC) designates this activity for 1.0 contact hour/0.1 CEUs of pharmacy contact hours.
The Universal Activity Number for this program is UAN JA0006235-0000-24-145-L01-P. This learning activity is knowledge-based. Your CE credits will be electronically submitted to the NABP upon successful completion of the activity. Pharmacists with questions can contact NABP customer service (custserv@nabp.net).
Global Learning Collaborative (GLC) has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credit(s). Approval is valid until December 3, 2024. PAs should claim only the credit commensurate with the extent of their participation in the activity.
Our ultimate goal is to improve the care being delivered to patients, and our high-quality, evidence-based CME initiatives reflect our dedication to the creation and execution of excellence and are the product of shared research, knowledge, and clinical practice skills across the healthcare continuum.
This activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company.
In this live webinar, a multidisciplinary faculty panel will review emerging evidence and evolving treatment guidelines related to cardio-renal-metabolic comorbidities (ie, type 2 diabetes, heart failure, chronic kidney disease, and management of post-MI) using clinical patience case vignettes.
1:30 – 1:35 PM
| Welcome and Introduction Melissa Magwire, RN |
1:35 – 1:45 PM
| Cardiologist Best Practices in the Management of Cardiometabolic Renal Outcomes Keith Miller, MD |
1:45 – 1:55 PM
| Nursing Best Practices in the Management of Cardiometabolic Renal Outcomes Melissa Magwire, RN |
1:55 – 2:05 PM | Pharmacy Best Practices in the Management of Cardiometabolic Renal Outcomes Matthew Bullington, PharmD
|
2:05 – 2:15 PM
| APP Best Practices in the Management of Cardiometabolic Renal Outcomes Dawn M. Denicola, NP
|
2:15 – 2:25 PM | Expert Panel Discussion – Pulling It All Together All Faculty
|
2:25 – 2:30 PM | Live Q&A All Faculty
|
In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.
Host:
Melissa Magwire, RN, MSN, CDE
Program Director, Cardiometabolic Center Alliance
Kansas City, MO
Melissa Magwire has reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months:
Consulting Fees: Amgen, Boehringer Ingelheim, Novo Nordisk
Faculty:
Matthew Bullington, PharmD
MHP Primary and Specialty Care
Shelbyville, IN
Matthew Bullington has reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months:
Ownership Interest: Lexicon Pharmaceuticals, Inc.
Dawn M. Denicola, FNP-C
Clinical Director, Heart Care Center
Heart Failure Coordinator
Our Lady of the Lake Regional Medical Center
Baton Rouge, LA
Dawn Denicola has reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months:
Has reported no relevant relationships
Keith Miller, MD
Cardiologist
Bryan Heart
Lincoln, NE
Dr. Miller has reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months:
Has reported no relevant relationships at this time
Reviewers/Content Planners/Authors:
After participating in this educational activity, participants should be better able to:
This activity is designed to meet the educational needs of cardiologists, nephrologists, and primary care physicians, as well as all other physicians, physician assistants, nurse practitioners, nurses, pharmacists, and other members of the interprofessional team who are involved in the management of patients with CVRM.
This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credit(s) for learning and change.
This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credit(s) for learning and change. In support of improving patient care, Global Learning Collaborative (GLC) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Global Learning Collaborative (GLC) designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Global Learning Collaborative (GLC) designates this activity for 1 nursing contact hour. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Global Learning Collaborative (GLC) designates this activity for 1.0 contact hour/0.1 CEUs of pharmacy contact hours.
The Universal Activity Number for this program is UAN JA0006235-0000-24-145-L01-P. This learning activity is knowledge-based. Your CE credits will be electronically submitted to the NABP upon successful completion of the activity. Pharmacists with questions can contact NABP customer service (custserv@nabp.net).
Global Learning Collaborative (GLC) has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credit(s). Approval is valid until December 3, 2024. PAs should claim only the credit commensurate with the extent of their participation in the activity.
Our ultimate goal is to improve the care being delivered to patients, and our high-quality, evidence-based CME initiatives reflect our dedication to the creation and execution of excellence and are the product of shared research, knowledge, and clinical practice skills across the healthcare continuum.
This activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company.
Stay current with the best on medical education
